| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/12/2012 | CN102020645B Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof |
| 12/12/2012 | CN102000225B Health care medicament for sobering, removing alcoholism and preventing and treating fatty liver and preparation method thereof |
| 12/12/2012 | CN101990436B Compositions and methods for treating neurodegenerative diseases |
| 12/12/2012 | CN101928234B 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same |
| 12/12/2012 | CN101757641B Preparation technique of cardamom volatile oil inclusion complex |
| 12/12/2012 | CN101744863B Persimmon leaf extract preparation, preparing method thereof and application thereof |
| 12/12/2012 | CN101732427B Medicinal composition for preventing and/or treating melancholia and climacteric syndrome |
| 12/12/2012 | CN101643432B New process for obtaining the crystalline form v of agomelatine |
| 12/12/2012 | CN101637259B Five flavored health wine and manufacturing method |
| 12/12/2012 | CN101610775B Analgesic agent comprising cyclic phosphatidic acid derivative |
| 12/12/2012 | CN101594868B A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect |
| 12/12/2012 | CN101506236B Monoclonal antibodies against amyloid beta protein and uses thereof |
| 12/12/2012 | CN101486677B 5HT2C receptor modulators |
| 12/12/2012 | CN101332193B Preparation method of fluvoxamine maleate medicine composition |
| 12/12/2012 | CN101027390B Lrp4/Corin dopamine-producing neuron precursor cell marker |
| 12/11/2012 | US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use |
| 12/11/2012 | US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 12/11/2012 | US8329886 Nucleic acid molecules encoding anti-amyloid beta antibodies |
| 12/11/2012 | US8329760 Pharmaceutical composition |
| 12/11/2012 | US8329742 Macrocyclic compounds useful as pharmaceuticals |
| 12/11/2012 | US8329735 Tetrazole compounds which selectively modulate the CB2 receptor |
| 12/11/2012 | US8329731 PTEN inhibitor or Maxi-K channels opener |
| 12/11/2012 | US8329701 Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
| 12/11/2012 | US8329662 Prodrug of an ICE inhibitor |
| 12/11/2012 | US8329654 Use of IL-6/IL-6 chimera in Huntington's disease |
| 12/11/2012 | US8329220 Controlled release formulations |
| 12/11/2012 | US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/11/2012 | US8329171 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody |
| 12/11/2012 | CA2661042C Agents for blood-brain barrier delivery |
| 12/11/2012 | CA2576144C Sigma receptor inhibitors |
| 12/11/2012 | CA2562539C Substituted cyclohexylcarboxylic acid derivatives |
| 12/11/2012 | CA2494008C Anti-myelin associated glycoprotein (mag) antibodies |
| 12/11/2012 | CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/11/2012 | CA2477516C Pharmaceutical formulation comprising melatonin |
| 12/11/2012 | CA2420061C Pharmaceutical composition for depot administration of rotigotine |
| 12/11/2012 | CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/09/2012 | CA2778850A1 New co-crystals of agomelatine, their preparation process and the pharmaceutical compositions in which they are found |
| 12/08/2012 | CA2779045A1 Synthesis process and crystalline form of benzamide 4-{3-¬cis-hexahydrocyclopenta¬c|pyrrol-2(1h)-yl|propoxy} hydrochloride as well as the pharmaceutical compositions in which it is found |
| 12/06/2012 | WO2012167281A2 Clinical application utilizing genetic data for effective medication management |
| 12/06/2012 | WO2012167133A2 Inhibitors of anandamide transport and their therapeutic uses |
| 12/06/2012 | WO2012166998A1 Compositions for sequential administration of opioid receptor agonists |
| 12/06/2012 | WO2012166891A2 Mu-opioid receptor binding compounds |
| 12/06/2012 | WO2012166862A1 Compositions and methods for treating alzheimer's disease |
| 12/06/2012 | WO2012166544A1 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders |
| 12/06/2012 | WO2012166463A2 Aminooxazole inhibitors of cyclin dependent kinases |
| 12/06/2012 | WO2012166004A1 Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof |
| 12/06/2012 | WO2012165985A1 An analgesic pharmaceutical composition for oral administration |
| 12/06/2012 | WO2012165984A1 Clenbuterol for use in treatment of autism |
| 12/06/2012 | WO2012165981A1 Novel hybrid cholinesterase inhibitors |
| 12/06/2012 | WO2012165925A2 Anti-c-met antibody having hgf activity and use thereof |
| 12/06/2012 | WO2012165731A1 Novel usage of rice, rice bran, or chaff extract as histamine receptor antagonist |
| 12/06/2012 | WO2012165586A1 Brain function improving agent |
| 12/06/2012 | WO2012165406A1 Psychic energizer agent and psychic energizer composition |
| 12/06/2012 | WO2012165314A1 Amide compound |
| 12/06/2012 | WO2012165254A1 Ropinirole-containing adhesive skin patch and packaged product thereof |
| 12/06/2012 | WO2012165253A1 Ropinirole-containing adhesive patch and packaging therefor |
| 12/06/2012 | WO2012164494A1 Composition for controlled release of buprenorphine |
| 12/06/2012 | WO2012164356A1 A method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders |
| 12/06/2012 | WO2012164118A1 Bioactive polyphenolic compounds containing sulphur or selenium and uses thereof |
| 12/06/2012 | WO2012164085A1 Glycine b antagonists |
| 12/06/2012 | WO2012164055A2 New compounds, synthesis and use thereof in the treatment of pain |
| 12/06/2012 | WO2012163790A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors |
| 12/06/2012 | WO2012163665A1 Transdermal therapeutic system comprising buprenorphine and an alpha-hydroxy acid |
| 12/06/2012 | WO2012163542A1 Vegf-d/vegfr2/3-mediated regulation of dendrites |
| 12/06/2012 | WO2012163456A1 Novel p2x7r antagonists and their use |
| 12/06/2012 | WO2012163365A1 Combinations of serotonin receptor agonists for treatment of movement disorders |
| 12/06/2012 | WO2012163179A1 Hexahydrodibenzo[a,g]quinolizine compound, preparation method therefor, pharmaceutical composition and use thereof |
| 12/06/2012 | WO2012162758A1 Method of treating the effects of stroke |
| 12/06/2012 | WO2012139043A3 Selective neuronal nitric oxide synthase inhibitors |
| 12/06/2012 | WO2012127506A4 Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| 12/06/2012 | WO2012121919A3 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same |
| 12/06/2012 | US20120310187 Transparent transdermal nicotine delivery devices |
| 12/06/2012 | US20120309841 Method of Inhibiting Chronification of Pain |
| 12/06/2012 | US20120309840 Treatment of Pain Associated with Trigeminal Neuralgia |
| 12/06/2012 | US20120309838 Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd) |
| 12/06/2012 | US20120309836 Methods and compositions for administration of trpv1 agonists |
| 12/06/2012 | US20120309833 Novel bexarotene analogs |
| 12/06/2012 | US20120309826 Stabilized pediatric suspension of carisbamate |
| 12/06/2012 | US20120309823 Percutaneous absorption preparations |
| 12/06/2012 | US20120309822 Treatment of infectious diseases |
| 12/06/2012 | US20120309816 Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo |
| 12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/06/2012 | US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences |
| 12/06/2012 | US20120309804 Compositions and methods for treatment of glaucoma |
| 12/06/2012 | US20120309800 Metalloenzyme inhibitor compounds |
| 12/06/2012 | US20120309795 Heterocyclic inhibitors of necroptosis |
| 12/06/2012 | US20120309793 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 12/06/2012 | US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators |
| 12/06/2012 | US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 12/06/2012 | US20120309789 Compounds which have activity at M1 receptor and their uses in medicine |
| 12/06/2012 | US20120309788 Method for Treating Alzheimer's Disease Using Pharmacological Chaperones To Increase The Activity of Gangliosidases |
| 12/06/2012 | US20120309787 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| 12/06/2012 | US20120309785 Use of Cysteamine in Treating Parkinson's Disease |
| 12/06/2012 | US20120309781 TETRAHYDRO-beta-CARBOLINE DERIVATIVES, SYNTHESIS AND USE THEREOF |
| 12/06/2012 | US20120309779 Methods and compositions comprising sequential administration of opioid receptor agonists |
| 12/06/2012 | US20120309778 Fused and Spirocycle Compounds and the Use Thereof |
| 12/06/2012 | US20120309776 Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors |
| 12/06/2012 | US20120309774 Selective antagonists of a2a adenosine receptors |
| 12/06/2012 | US20120309764 Heteroaromatic aryl triazole derivatives as PDE10A enzyme inhibitors |
| 12/06/2012 | US20120309759 Screening Method and Compounds for Modulating Telomerase Activity |